Anixa Biosciences (ANIX) Competitors

Aura Biosciences (NASDAQ:AURA) and Anixa Biosciences (NASDAQ:ANIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.

Is AURA or ANIX more profitable?

Aura Biosciences' return on equity of -41.57% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aura Biosciences	N/A	-41.57%	-36.43%
Anixa Biosciences	N/A	-58.55%	-53.29%

Do institutionals and insiders believe in AURA or ANIX?

96.8% of Aura Biosciences shares are owned by institutional investors. Comparatively, 29.1% of Anixa Biosciences shares are owned by institutional investors. 5.4% of Aura Biosciences shares are owned by insiders. Comparatively, 25.3% of Anixa Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has better valuation & earnings, AURA or ANIX?

Anixa Biosciences has higher revenue and earnings than Aura Biosciences. Anixa Biosciences is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aura Biosciences	N/A	N/A	-$76.41M	-$1.73	-4.41
Anixa Biosciences	$210K	479.12	-$12.55M	-$0.39	-8.01

Which has more risk & volatility, AURA or ANIX?

Aura Biosciences has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Comparatively, Anixa Biosciences has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

Does the MarketBeat Community believe in AURA or ANIX?

Anixa Biosciences received 3 more outperform votes than Aura Biosciences when rated by MarketBeat users. Likewise, 72.97% of users gave Anixa Biosciences an outperform vote while only 63.16% of users gave Aura Biosciences an outperform vote.

Company	Underperform	Outperform
Aura Biosciences	Outperform Votes 24 63.16%	Underperform Votes 14 36.84%
Anixa Biosciences	Outperform Votes 27 72.97%	Underperform Votes 10 27.03%

Do analysts recommend AURA or ANIX?

Aura Biosciences presently has a consensus target price of $23.00, indicating a potential upside of 201.44%. Anixa Biosciences has a consensus target price of $8.50, indicating a potential upside of 172.00%. Given Aura Biosciences' higher possible upside, research analysts plainly believe Aura Biosciences is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aura Biosciences	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.29
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Does the media prefer AURA or ANIX?

In the previous week, Aura Biosciences had 2 more articles in the media than Anixa Biosciences. MarketBeat recorded 10 mentions for Aura Biosciences and 8 mentions for Anixa Biosciences. Aura Biosciences' average media sentiment score of 0.78 beat Anixa Biosciences' score of 0.36 indicating that Aura Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aura Biosciences	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anixa Biosciences	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Aura Biosciences beats Anixa Biosciences on 9 of the 17 factors compared between the two stocks.